Paclitaxel/carboplatin/etoposide (PCE) therapy for advanced poorly differentiated neuroendocrine (PDNE) carcinoma: A Minnie Pearl Cancer Research Network phase II trial.

被引：0
|
作者：
Miranda, FT
Spigel, DR
Hainsworth, JD
Thompson, DS
Yardley, DA
Burris, HA
Litchy, S
Shrader, M
Hon, JK
Corso, SW
Greco, FA
机构：
[1] Sarah Cannon Res Inst Tennessee, Nashville, TN USA
[2] Comprehens Canc Inst, Huntsville, AL USA
[3] Upstate Carolina CCOP, Spartanburg, SC USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：322S / 322S
页数：1
相关论文
共 50 条
  • [41] Phase II trial of combination nab-paclitaxel, carboplatin and gemcitabine in first line therapy of advanced urothelial carcinoma
    Alva, Ajjai
    Daignault, Stephanie
    Smith, David C.
    Hussain, Maha
    INVESTIGATIONAL NEW DRUGS, 2014, 32 (01) : 188 - 194
  • [42] Long-term follow-up of patients treated with paclitaxel/carboplatin-based chemotherapy for advanced non-small-cell lung cancer: Sequential phase II trials of the Minnie Pearl Cancer Research Network
    Hainsworth, JD
    Gray, JR
    Morrissey, LH
    Kalman, LA
    Hon, JK
    Greco, FA
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (13) : 2937 - 2942
  • [43] Preoperative docetaxel and gemcitabine in resectable non-small cell lung cancer: A phase II trial of the Minnie Pearl Cancer Research Network
    Thompson, D. S.
    Spigel, D. R.
    Greco, F. A.
    Yardley, D. A.
    Burris, H. A., III
    Vazquez, E.
    Erland, J.
    Shipley, D. L.
    Spremulli, E.
    Hainsworth, J. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [44] Docetaxel and epirubicin as first-line treatment for patients with metastatic breast cancer: A minnie pearl cancer research network phase II trial
    Hainsworth, John D.
    Yardley, Denise A.
    Spigel, David R.
    Meluch, Anthony A.
    Rinaldi, David
    Schnell, Frederick M.
    Greco, F. Anthony
    CANCER INVESTIGATION, 2006, 24 (05) : 469 - 473
  • [45] A Big Ten Cancer Research Consortium phase II trial of pembrolizumab with carboplatin and paclitaxel for advanced or recurrent endometrial cancer.
    Pineda, Mario Javier
    Schilder, Jeanne
    Hill, Emily K.
    Teoh, Deanna Gek Koon
    Barber, Emma Longley
    Robertson, Sharon E.
    Strohl, Anna Everett
    Xu, Jiahui
    Kocherginsky, Masha
    Matei, Daniela
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [46] Phase II trial of rituximab and short duration chemotherapy followed by 90Y-ibritumomab tiuxetan as first-line treatment for patients with follicular lymphoma:: A Minnie Pearl Cancer Research Network phase II trial.
    Shipley, DL
    Spigel, DR
    Carrell, DL
    Dannaher, C
    Greco, FA
    Hainsworth, JD
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 562S - 562S
  • [47] Phase II trial of topotecan, carboplatin, and paclitaxel as front-line therapy in suboptimal advanced epithelial ovarian cancer
    Bolis, G
    Scarfone, G
    Villa, A
    Parazzini, F
    GYNECOLOGIC ONCOLOGY, 2001, 81 (02) : 331 - 333
  • [48] Etoposide and cisplatin versus irinotecan and cisplatin as the first-line therapy for patients with advanced, poorly differentiated gastroenteropancreatic neuroendocrine carcinoma: A randomized phase 2 study
    Zhang, Panpan
    Li, Jie
    Li, Jian
    Zhang, Xiaotian
    Zhou, Jun
    Wang, Xicheng
    Peng, Zhi
    Shen, Lin
    Lu, Ming
    CANCER, 2020, 126 : 2086 - 2092
  • [49] Induction chemotherapy plus gefitinib followed by concurrent chemotherapy/ radiation therapy/gefitinib for patients (pts) with locally advanced squamous carcinoma of the head and neck: A phase I/II trial of the Minnie Pearl Cancer Research Network.
    Doss, H. H.
    Greco, F. A.
    Meluch, A. A.
    Gray, J. R.
    Spigel, D. R.
    Shipley, D. L.
    Barton, J. H.
    Kuzur, M. E.
    Ramsey, S.
    Lunin, S. D.
    Hainsworth, J. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 290S - 290S
  • [50] A multicenter phase II trial of paclitaxel, carboplatin and cetuximab (PCE) followed by chemoradiotherapy in patients with unresectable locally advanced squamous cell carcinoma of the head and neck (SCCHN)
    Enokida, T.
    Ogawa, T.
    Homma, A.
    Okami, K.
    Minami, S.
    Iwae, S.
    Nakanome, A.
    Shimizu, Y.
    Motegi, A.
    Maki, D.
    Ueda, Y.
    Fujisawa, T.
    Nomura, S.
    Okano, S.
    Tahara, M.
    ANNALS OF ONCOLOGY, 2018, 29
12345